Background. The precision of the metaphase-anaphase transition ensures stable genetic inheritance. The spindle checkpoint blocks anaphase onset until the last chromosome biorients at metaphase plate, then the bonds between sister chromatids are removed and disjoined chromatids segregate to the spindle poles. But, how sister separation is triggered is not fully understood. Principal Findings. We identify PIASc as a human E3 sumo ligase required for timely and efficient sister chromatid separation. In cells lacking PIASc, normal metaphase plates form, but the spindle checkpoint is activated, leading to a prolonged metaphase block. Sister chromatids remain cohered even if cohesin is removed by depletion of hSgo1, because DNA catenations persist at centromeres. PIASc-depleted cells cannot properly localize Topoisomerase II at centromeres or in the cores of mitotic chromosomes, providing a functional link between PIASc and Topoisomerase II. Conclusions. PIASc directs Topoisomerase II to specific chromosome regions that require efficient removal of DNA catenations prior to anaphase. The lack of this activity activates the spindle checkpoint, protecting cells from non-disjunction. Because DNA catenations persist without PIASc in the absence of cohesin, removal of catenations and cohesin rings must be regulated in parallel.
INTRODUCTION
Cohesion between sister chromatids must be maintained from the time of its establishment, coupled to DNA replication, until it is rapidly removed in early anaphase allowing the sister chromatids to disjoin and chromosomes to segregate to each daughter cell. It had been proposed that cohesion depends on the catenations that form between sister DNA duplexes as a consequence of their replication [1] , but pivotal studies later demonstrated that proteolysis is required for chromatid separation, indicating that a protein ''glue'' physically links the chromatids of each chromosome [2, 3] . Mutants of genetically amenable lower eukaryotes provided support for this model [4] . An inhibitor of anaphase, Pds1, was identified in budding yeast [5, 6] and this unstable protein was found to be a substrate of a ubiquitin ligase that covalently marks proteins for proteasomal degradation [7] . Although Pds1 itself does not bind to DNA, it was shown to be an important regulator of a protease (Esp1) that cleaves the Rad21/ Mcd1 component of the so-called cohesin complex that glues the sister chromatids together (reviewed in [8] ). The ubiquitin ligase, now known as the Anaphase Promoting Complex/Cyclosome (APC/C), was purified from clam oocytes [9] and characterized in organisms including yeasts and frogs [10, 11] .
In keeping with the model that the metaphase-anaphase transition is triggered by proteolysis, yeasts deficient in APC/C activity arrest in metaphase with bioriented chromosomes aligned correctly at the spindle equator but unable to separate their sister chromatids [12] . In mammals, efficient sister chromatid separation also requires the APC/C [13, 14] but it is likely that the control of anaphase initiation is more complex in higher eukaryotes because additional mechanisms are required to enhance the fidelity of segregation of very large genomes. Indeed, studies in the Xenopus egg extract system implicated an additional factor, other than the APC/C, in the regulation of chromatid disjunction. Inactivation of PIASc in Xenopus egg extracts interfered with chromatid disjunction [15, 16] , and this E3 sumo ligase was shown to both sumoylate Topoisomerase II and have substrates at the centromeres of mitotic chromosomes [15, 16] . Since Topoisomerase II is the only enzyme capable of removing catenations from between sister chromatids, this provided a possible link between decatenation and chromatid separation. Orthologs of PIASc in yeasts, however, sumoylate cohesin components and other known regulators of sister cohesion, such as Pds5 [17] [18] [19] , in addition to topoisomerase II [20, 21] . It therefore remains unknown what are the key substrates of PIASc important for mitosis in Xenopus and yeast. Moreover, no mitotic functions have been ascribed to mammalian sumo ligases and PIASc null mice have been reported to be viable [22] .
Here we demonstrate that human PIASc is required for timely anaphase onset and efficient sister chromatid disjunction. Perhaps due to a failure to release centromere cohesion in PIASc-depleted cells, an Aurora B-and Mad2-dependent checkpoint is activated. This leads to a prolonged block in metaphase during which in some cells several chromosomes then depart from the equatorial metaphase plate but remain cohered at their centromeres. When anaphase proceeds upon chemical inhibition of Aurora B, sister chromatid separation is rarely complete, indicating a defect in loss of cohesion without PIASc. We show that cohesin can be removed from chromosomes without PIASc, but DNA catenations remain and can provide a cohesin-independent physical sister centromere association that is cytologically indistinguishable from that in normal chromosomes. Finally, we observe that PIASc-depleted cells are unable to properly localize Topoisomerase II to centromere regions and mitotic chromosome cores, providing the first functional connection between PIASc and Topoisomerase II in mammals. Inefficient removal of DNA catenations in PIAScdepleted cells is therefore a likely cause of checkpoint activation and the defect in loss of cohesion.
RESULTS

PIASc is required for timely anaphase onset in human cells
Based on the hypothesis that the E3 sumo ligase PIASc contributes to the regulation of sister separation in human cells, we sought to test if depletion of PIASc perturbs mitotic progression. We devised a protocol that allowed depletion of PIASc from HeLa cells simultaneously with cell cycle synchrony in early S-phase (Fig. 1A,B) . Briefly, control or PIASc-specific siRNA was added to asynchronously growing HeLa cells at 30% confluence, the siRNA was removed after 6 hours, then after 18 hours a doublethymidine synchrony procedure was employed. Samples were taken every 2 hours after release and processed for cytological and biochemical analysis. Upon release from early S-phase, controltreated and PIASc-specific siRNA-treated cells first entered mitosis after ,10 hours (Fig. 1C,I ). While most control cells had reached the subsequent G1 phase by 14 hours, PIASc siRNA-treated cells accumulated in mitosis (,35%) and the mitotic index remained high up to 24 hours after the release of the thymidine block (Fig. 1I ,J and data not shown). This mitotic delay was also evident in the high levels of cyclin B and phosphorylated histone H3 (PH3) during this time frame (Fig. 1C) . The cells in mitosis lacked PIASc protein as judged by Western blot, whereas PIASc protein was detectable in the population of interphase cells (Fig. 1B) , indicating that those cells which accumulated in mitosis were the same cells in which PIASc protein had been efficiently depleted. Analysis of the cytology of the mitotic cells revealed that most had metaphase chromosome arrangements indistinguishable from control metaphases (Fig. 1D,E) . That is, the chromosomes were organized into a metaphase plate arrangement and centromeric regions of the chromosomes possessed distinct primary constrictions. Many of these cells must have endured a prolonged delay in mitosis because at the later time points (18-24 hrs) they displayed over-condensed chromosomes typical of cells in which anaphase onset had been blocked (Fig. 1F,G) . Also at later time points, similar cells with overcondensed chromosomes had several chromosomes positioned off the metaphase plate (Fig. 1H ). Very few cells lacking PIASc were observed with separated sister chromatids (Fig. 1J ). (For a more detailed description of these phenotypes of PIASc-depleted cells see Fig. S1 and S2.) These data indicate that PIASc is needed for the metaphase-to-anaphase transition in human cells and therefore suggest that sumoylation of mitotic substrates is a key component of anaphase initiation.
Metaphase plates form normally without PIASc but chromosomes can then leave the plate That a maximum of 35% of the cells accumulated in mitosis after PIASc depletion (Fig. 1I and data not shown) suggested either that the cells entered mitosis more slowly than in controls, or that the cells eventually exited mitosis after delaying in metaphase (or a combination of both of these factors). Slower entry into mitosis was consistent with the result that, when the above time course experiment was repeated in the presence of nocodazole, PIAScdepleted cells accumulated in mitosis to a lesser extent than controls (Fig. 1K) . However, to determine if some cells exited mitosis after PIASc-depletion, and to gain a more detailed understanding of the mitotic defect in live cells, we performed 16-20 hour time-lapse analyses of HeLa cells possessing a fluorescent tagged histone (H2B-GFP) [23] following early S-phase synchrony (Fig. 2, Fig. S3 , Table S1 , and Movies S1-S4).
In controls, mitosis proceeded normally ( Fig. 2A,B, Fig. S3 and Table S1 ), and cell synchrony was evidently sharp since 33/51 (64%) of the cells within a particular field progressed into mitosis during a short 4 hour time period (10-14 hours after release from early S-phase). PIASc-depleted cells also reached mitosis quite synchronously with over half of the cells in a single field initiating mitosis within a 5 hour time frame after release from early S-phase (Fig. S3) . Consistent with the time course experiment described in Fig. 1 , most PIASc-depleted cells became strongly delayed in mitosis. The average time spent in mitosis was 6 hours 35 minutes (s.d. = 3 hours 56 minutes; n = 26), compared with 69 minutes in control cells (s.d. = 24 minutes; n = 36).
PIASc-depleted cells usually performed prometaphase with normal timing forming bona fide metaphase plates (Fig. 2C,D, Fig.  S3 and Table S1 ). In these cells, metaphase lasted 1-66longer than in control cells (on average 110 minutes with s.d. = 78 minutes, compared with 44 minutes with s.d. = 25 minutes in controls). The maximum length of metaphase recorded was 4 hours 10 minutes. Following the prolonged metaphase period, two alternative outcomes were observed, either (i) the cell initiated anaphase (Fig. 2C) and occasionally, lagging chromosomes were observed (see bottom cell in Movie S3 that corresponds to Fig. 2C ; see arrows) or anaphase initiation was asynchronous (see Fig. S1P ), or (ii) several chromosomes departed from the metaphase plate and migrated toward a spindle pole (Fig. 2D, top cell) . In this latter category, the cells appeared to have reverted to a prometaphase-like state; in some cases these cells recovered complete metaphase alignment of all chromosomes and at a later stage, after further delay in metaphase, were able to perform anaphase (Fig. 2D, bottom cell) . Other cells in this category remained in this ''de-congressed'' metaphase state until the end of the time-lapse movie (Fig. 2D, top cell) .
Together with the cytological analysis in Figure 1 and Figure  S1 , these live cell imaging studies provide a detailed description of the mitotic defects caused by PIASc-depletion. Most cells reach metaphase in a timely manner and form apparently normal metaphase plates. After a prolonged metaphase delay cells either performed anaphase or a small number of chromosomes left the plate and migrated to the spindle poles. This de-congressed metaphase state was maintained in most cells for many hours.
The spindle checkpoint ought to be satisfied without PIASc but centromeres remain cohered That metaphase plates formed normally without PIASc but anaphase failed to initiate on time seemed counterintuitive. The time-lapse studies indicated that when initiated, anaphase proceeded normally in some PIASc-depleted cells, indicating a functional mitotic spindle and motors. In agreement, immunostaining of alpha-tubulin revealed mitotic spindles that were indistinguishable from control metaphases in cells lacking PIASc (Fig. 3A,G) . Moreover, the kinetochores of chromosomes at the metaphase plate in both control cells and cells that lacked PIASc clearly possessed far less CENP-E than kinetochores of chromo-somes away from the plate (Fig. 3B-F,H-K) . This staining pattern is typical of spindle checkpoint inactivation after congression of each chromosome to the metaphase plate [24, 25] . That metaphase plates formed in PIASc-depleted cells which were indistinguishable from control metaphase plates, also argues that the spindle checkpoint ought to have been silenced because biorientation of chromosomes at the metaphase plate can only occur if proper kinetochore-microtubule attachments are made, resulting in a balance of opposite forces exerted by the spindle on each cohered sister and producing the proper spindle tension on each chromosome. Therefore, the prolonged metaphase delays in PIASc-depleted cells indicate that a mitotic checkpoint is able to act in metaphase: this has only been previously reported to occur in response to inhibition of Topoisomerase II [26] [27] [28] .
An Aurora B-dependent and Mad2-dependent checkpoint is activated following PIASc depletion
The above findings indicated that a lack of PIASc might have triggered a mitotic checkpoint. Although the spindle checkpoint appeared to have been silenced in metaphases lacking PIASc, based on the reduction of CENP-E staining at kinetochores, we found that co-depletion, using RNAi, of Mad2 and PIASc abrogated the accumulation of cells in mitosis following release from a double thymidine synchrony (data not shown). We also found that the small molecule inhibitor of Aurora B, ZM447439 [29] , was able to relieve the metaphase arrest (Fig. 4) . In control cells that were depleted of Hec1, a treatment that induces a persistent spindle checkpoint arrest [30] , addition of ZM447439 resulted in rapid sister separation followed by mitotic exit in almost all cells ( Fig. 4A-E) . Similarly, after we collected PIASc-depleted mitotic cells by mitotic shake-off then added ZM447439, most cells rapidly performed sister chromatid separation and segregation, followed by mitotic exit (Fig. 4F-J ). Anaphase and mitotic exit could have been a result of cyclin B degradation upon ZM447439 treatment. Consistent with this, addition of the Cdk inhibitor roscovitine had similar effects on PIASc-depleted cells ( Fig. 4K-O) , inducing chromatid separation, segregation to the spindle poles and mitotic exit. These experiments therefore resolved several important issues. First, PIASc-depleted cells are largely capable of removing the cohesion from between the sisters as long as Cdkcyclin B is inactivated. Second, as seen in the time-lapse studies, PIASc-depleted cells treated with ZM447439 or roscovitine must have possessed functional mitotic spindles because chromosomes segregated to the spindle poles before decondensing in telophase. Third, the metaphase delay imposed by PIASc depletion is a checkpoint response.
Checkpoints can monitor defects in biological processes and respond by delaying cell cycle progression [8] . The metaphase delay in PIASc-depleted cells is typical of a checkpoint response because anaphase onset is blocked despite being mechanically able to proceed, the delay can be bypassed by chemical inhibition of one of the checkpoint components (in this case Aurora B), and the delay is spontaneously overcome in some cells even though a successful anaphase could not always be completed. When overridden by ZM447439 or roscovitine, chromatid disjunction was rarely efficient (Fig. 4F-O) . Typically, bypass of a checkpoint delay reveals the cellular aberration that activated the checkpoint. In the case of the delay in PIASc-depleted cells, checkpoint bypass revealed multiple chromatin bridges between the dividing nuclei in almost every cell. Laggard chromosomes were also seen in some of the anaphases in the time-lapse movies of PIASc-depleted cells that had previously delayed in metaphase for a prolonged period. These data indicate that the defect in PIASc-depleted cells might be an inability to efficiently separate the sister chromatids.
PIASc is required for sister separation in hSgo1-depleted cells
The lack of PIASc resulted in checkpoint activation at the metaphase-to-anaphase transition and the cells failed to remove cohesion from the centromeres. However, the above experiments did not address directly if the lack of PIASc perturbed the removal of cohesin. A number of important studies have shown that sister chromatid cohesion cannot be maintained in cells depleted of the cohesin protector hSgo1, even under conditions in which the spindle checkpoint is active [13, [31] [32] [33] [34] [35] . These results demonstrated that without hSgo1, cells are oblivious to spindle checkpoint controls and that cohesin is rapidly removed from chromosomes upon nuclear envelope breakdown. If PIASc depletion arrested cells in metaphase by activating the spindle checkpoint, but has no direct role related to chromosome cohesion, then depletion of hSgo1 should relieve sister chromatid cohesion after PIASc knockdown. As previously described, we could efficiently deplete HeLa cells of hSgo1 by RNA interference (data not shown) and found that, similar to previous reports, the cells accumulated in mitosis with all of their sister chromatids fully separated, even in the presence of nocodazole [13] . In the absence of hSgo1, sister chromatids were similarly able to separate in cells in which APC/ C activity had been eliminated by depletion of the Apc2 component of the catalytic site and by the simultaneous addition of nocodazole (Fig. 5A,B) . Furthermore, if the spindle checkpoint was persistently activated by depletion of Hec1 (Fig. 5C ), simultaneous depletion of hSgo1 resulted in complete loss of sister cohesion (Fig. 5D) . Each of these experiments confirms that the known spindle checkpoint pathways are unable to preserve cohesion in the absence of cohesin guardian hSgo1.
We depleted both PIASc and hSgo1 in synchronized HeLa cells using RNAi (data not shown) and a double thymidine block protocol, then released into the cell cycle either with or without nocodazole. As previously reported, hSgo1-depleted cells accumulated in mitosis with separated sister chromatids, whether or not nocodazole was present in the medium, and cell cycle progression was blocked in a telophase-like state (Fig. 5G,J,L,N) .
Unexpectedly, however, the doubly depleted HeLa cells lacking PIASc and hSgo1 accumulated in metaphase/de-congressed metaphase with cohered sister chromatids (Fig. 5H-J,M,N) , just like the cells depleted of PIASc only (Fig. 5E,F,K) . Thus, remarkably, even in the absence of the cohesin protector hSgo1, PIASc is required for sister chromatid separation. The same result was observed when PIASc was depleted simultaneously with Sororin, a protein that interacts physically with the cohesin complex and is required for sister chromatid cohesion in mitosis (data not shown) [36, 37] . Together these experiments indicate that PIASc might be directly involved in the removal of cohesion.
PIASc is not required for removal of cohesin from centromeres
The lack of sister separation in PIASc/hSgo1 doubly depleted cells could be explained in one of two ways: either, (1) PIASc is required for cohesin removal even in the absence of the cohesin guardian, or (2) sister chromatids remain cohered at the centromeres in the absence of cohesin. To test this we immuno-localized Rad21 in cells after PIASc-depletion, hSgo1-depletion, or in doubly depleted cells. As expected, mitotic chromosomes in hSgo1-depleted cells lacked any detectable cohesin except before breakdown of the nuclear envelope, in which case cohesin was strongly detected throughout the nucleus (Fig. 5Q,Q9 ). PIASc-depleted mitotic cells, however, like control cells, possessed clearly defined regions of centromeric Rad21 between the paired kinetochores of each cohered chromosome (Fig. 5P,P9 ). Some Rad21 was also seen between the chromosome arms (Fig. 5O,O9,P,P9) . Strikingly, Rad21 could not be observed between the paired kinetochores or the arms of the cohered sisters in hSgo1/PIASc doubly depleted cells (Fig. 5R,R9) . Therefore, PIASc is not required for removal of cohesin from chromosomes that occurs in the absence of hSgo1, but PIASc is required for sister chromatid separation under the same experimental conditions. Thus, cohesion between sister kinetochores was maintained in the absence of detectable Rad21.
DNA catenations
A known mechanism that joins sister chromatids, though not known to be strictly regulated, is DNA catenation, that arises as sister DNA molecules are synthesized during S-phase. In budding yeast and Xenopus, PIASc-mediated sumoylation of DNA Topoisomerase II, the only enzyme capable of removing catenations from between sister chromatids, is thought to target Topoisomerase II to centromeres or pericentric regions of chromosomes during mitosis [16, 21] . It was therefore plausible that catenations, in addition to cohesin, linked the sister chromatids in PIASc-depleted cells. This could explain why PIASc and hSgo1 doubly depleted cells retained sister chromatid cohesion in the absence of cohesin and would be indicative of a need for PIASc for catenation removal. To test this hypothesis we employed a specific inhibitor of Topoisomerase II, , that locks the enzyme in the so-called ''closed-clamp'' form, preventing concatenated sister duplexes from being resolved. We depleted PIASc from HeLa cells before a double thymidine synchrony and then collected the cells that became arrested in mitosis after release from the S-phase block. As described in Figure 4 , the Cdk inhibitor roscovitine or the Aurora B inhibitor ZM447439 caused such mitotic cells to separate most of their sister chromatids and then segregate them to the spindle poles, demonstrating that sister chromatid cohesion was largely removed. If PIASc-depleted mitotic cells possess catenations that hold the sister DNA molecules together, then inhibition of Topoisomerase II ought to block the sister separation that is forced upon roscovitine or ZM447439 treatment. We added roscovitine (data not shown) or ZM447439 to the PIASc-depleted mitotic cells simultaneously with ICRF-193 and prepared samples for cytology. Strikingly, inhibition of Topoisomerase II completely blocked sister chromatid separation in every cell observed. That Topoisomerase II was required for sister separation under these conditions, indicates that catenations were indeed present in the PIASc-depleted metaphase-arrested cells (Fig. 6A-E) .
PIASc is required for efficient localization of Topoisomerase II to centromere regions and chromosome cores in mitotic human cells
If indeed catenations could not be removed efficiently from the centromeres of PIASc-depleted cells, then these catenations must have persisted despite the fact that Topoisomerase II is active in mitotic cells. One mechanism that could account for this apparent paradox would be if PIASc helps to direct the decatenatory activity of Topoisomerase II to centromeric catenations. To test this hypothesis, we immuno-localized Topoisomerase IIa in control mitotic cells and in cells depleted of PIASc (Fig. 6F-J) . During mitosis, Topoisomerase II is associated with the axial cores that run the length of condensed chromosome arms, but is also specifically concentrated at the centromere regions [38] [39] [40] [41] [42] [43] . Using polyclonal antisera directed at Topoisomerase IIa, we reproducibly observed this staining pattern (core localization and intense staining at the centromere region) in almost 90% of the control cells (Fig. 6F,G,J) . Strikingly, however, fewer than 5% of PIAScdepleted mitotic cells had this staining pattern. Instead, almost 40% of PIASc-depleted mitotic cells had prominent staining of the chromosome cores along the chromosome arms, but lacked the intense staining at the centromere regions (Fig. 6I,J) . A further 48% of the PIASc-depleted cells had a pattern of diffuse staining coincident with the chromatin, but not well localized to the cores or centromere regions (Fig. 6H,J) . Other proteins that specifically localize to centromere regions during mitosis, such as INCENP and CENP-F, localized to centromeres equally well in control and PIASc-depleted mitotic cells (Fig. 6J and data not shown). These data are consistent with a need for PIASc for proper localization of Topoisomerase II to centromere regions of chromosomes in mitosis and further suggest that localization to chromosome cores is less efficient in the absence of PIASc.
DISCUSSION Two different mechanisms regulate sister chromatid cohesion
Separation of sister chromatids at the metaphase-anaphase transition is the key moment of the mitotic cell cycle and its accuracy allows faithful partitioning of the duplicated genome. Groundbreaking studies have described a cohesin-based system that physically holds sister chromatids together and the mechanisms that regulate dissolution of this glue in preparation for anaphase [44] . In yeasts, firm genetic evidence has established that cohesin is the predominant, if not the sole, factor that accounts for sister cohesion and DNA catenations are removed from yeast chromosomes well before anaphase onset [45] . But in vertebrates, unlike in yeast, DNA catenations as well as cohesin complexes are present at centromeres until anaphase [46, 47] . Whether centromeric DNA catenations play an important functional role, rather than persisting as a mere coincidence, has not been understood because evidence that the catenation state of DNA is regulated through the cell cycle has been lacking. It is clear, however, that mechanisms must exist to ensure the efficient removal of centromeric catenations once the commitment to separate sister chromatids has been made. Here we provide the first hint that DNA catenations between human sister chromatids are specifically targeted for removal at or just prior to anaphase onset and that centromeric decatenation is regulated by distinct mechanisms from those which orchestrate removal of cohesin from the centromere. Our data suggest that a sumo ligase, PIASc, promotes sister decatenation in preparation for or during sister separation, by specifically targeting Topoisomerase II to centromeric regions where catenations remain until anaphase.
In metaphase mammalian cells cohesin complexes persist at the centromeres [48] . DNA catenation must also exist at the centromeres in metaphase because Topoisomerase II inhibitors block chromatid disjunction when added to cells just prior to anaphase onset [46, 47] . We have shown that HeLa cells depleted Apc2) is depleted together with the cohesin protector hSgo1. RNAi was performed as previously described [13] and cells allowed to reach mitosis after early S-phase synchrony in the presence of nocodazole: (A) c-mitosis arrest with nocodazole after Apc2 depletion; (B) complete sister chromatid separation in the presence of nocodazole after hSgo1 and Apc2 co-depletion. (C,D) hSgo1 is required for sister cohesion when a persistent spindle checkpoint is induced by Hec1-depletion (cells were synchronized and Hec1/hSgo1 depleted as described in Figure 3 and [13] ): (C) Prometaphase arrest after Hec1-depletion; (D) complete sister separation after hSgo1 and Hec1 co-depletion. Numbers on these micrographs (A-D) indicate % cells that arrested with these phenotypes 20 hours of PIASc suffer a prolonged metaphase block in which cohesin and catenations are maintained at the centromere, just like in normal metaphase cells. However, upon removal of cohesin from these centromeres by co-depletion of hSgo1, DNA catenations remain between the sister chromatids. Thus, although the regulation of cohesin binding at centromeres clearly depends on the cohesin guardian hSgo1, the persistence of DNA catenations at centromeres does not depend on hSgo1 (in the absence of PIASc) nor does it depend on the presence of cohesin. In the apparent absence of cohesin at the centromere, PIASc/hSgo1 doubly depleted cells block in metaphase: chromosomes with cohered sisters remain at the metaphase plate, and must therefore be under tension from the mitotic spindle, but remain physically tethered by catenations. These data provide two novel conclusions about the mechanism of sister cohesion. Firstly, the persistence of catenations and cohesion are regulated independently, cohesin by factors such as separase, hSgo1 and Plk1, and catenations by PIASc and Topoisomerase II (Fig. 7) . Secondly, catenations do not persist in metaphase simply because the sisters are held in close proximity by cohesin complexes.
Does the spindle assembly checkpoint monitor the ability to decatenate centromeric DNA?
The kinetics of progression through mitosis after PIASc depletion revealed typical features of checkpoint activation: first, cells delayed progression to the next cell cycle stage (metaphase was prolonged compared to controls); second, the delay could be overridden spontaneously (as seen in the time-lapse movies) and by chemical treatment (Aurora B inhibition, Cdk inhibition); third, overriding the checkpoint revealed defects that the checkpoint was presumably aiming to avoid (anaphase chromatin bridges seen after chemical override, and laggard chromosomes and asynchronous anaphases after spontaneous override).
Our data indicate that without PIASc, cells become blocked in mitosis due to activation of an Aurora B-and Mad2-dependent checkpoint. Previous studies of the role of Aurora B in spindle checkpoint control indicated that Aurora B helps to sense and/or correct mono-polarly orientated chromosomes and merotelically attached kinetochores. We have not determined the precise molecular event that triggers activation of the checkpoint after PIASc depletion, but at a cytological level based on chromosome spreads, immuno-localization of CENP-E and live cell imaging, we could not detect a mitotic defect prior to metaphase chromosome alignment. That all of the chromosomes biorient at the metaphase plate in PIASc-depleted cells, discounts the possibility that monopolar orientation of chromosomes and, possibly, merotelic attachments are the cause of checkpoint activation. The majority of HeLa cells depleted of PIASc reached metaphase with kinetics indistinguishable from controls cells, then blocked in metaphase for a prolonged period (on average 2.56 the normal length of metaphase). In these metaphase cells filmed by time-lapse analysis, the typical movements of the metaphase plate occurred as in control cells, presumably indicating normal spindle and motor function. Indeed, proper alignment of all the chromosomes at the metaphase plate implies correct kinetochore, spindle and motor behavior as well as proper tension on each chromosome. The only molecular defects that we could provide evidence for in PIAScdepleted cells were the inability to remove centromeric catenations and a lack of Topoisomerase II localization to centromere regions (and mitotic chromosome cores in some cells). It is therefore possible that the anaphase checkpoint is induced in response to persistent centromeric catenations or the inability to remove these catenations efficiently. Other studies lend support to this model in that inhibition of Topoisomerase II, the only enzyme that can decatenate DNA, prior to anaphase onset induces a metaphase checkpoint delay [26] [27] [28] .
The separation of sister chromatids that occurs during mitosis in the Xenopus egg extract system also depends on PIASc. But in this in vitro system, the lack of PIASc did not result in a prolonged metaphase block, as we observed in HeLa cells depleted of PIASc [15] . This difference may simply reflect a limitation of the egg extract system or could, more interestingly, mean that Xenopus embryonic-like cell cycles lack the ability to activate a checkpoint in response to PIASc-depletion.
PIASc might promote efficient decatenation at the centromere
Similar to PIASc-depleted cells, Topo II inhibitor-treated cells block in metaphase with high levels of APC/C substrates such as securin and cyclin B [27] . An important difference between these two metaphase checkpoint arrested states, however, is that the Topo II inhibited cells are unable to separate their sister chromatids upon checkpoint bypass (due to the persistent catenations) whereas PIASc-depleted cells can separate most of their sister chromatids upon inactivation of Aurora B or Cdkcyclin B. It must therefore be the case that PIASc function is not absolutely required for Topo II-mediated decatenation. We therefore suggest that PIASc functions to promote efficient Topo II-mediated decatenation at the centromere, but that without PIASc, decatenation can still occur but perhaps without the precision necessary for faithful chromosome segregation at the moment of anaphase onset. In agreement with this hypothesis, Topoisomerase II localized diffusely on the chromosomes of PIASc-depleted cells rather than being concentrated at centromere regions and chromosome cores. It is noteworthy that although some of the PIASc-depleted cells that we filmed by time lapse-microscopy could perform anaphase, we observed defects in the synchrony of sister separation; accordingly, PIASc-depleted cells treated with Aurora B inhibitors could segregate their chromosomes, but not efficiently and chromosome bridges were always seen between the dividing cells. Together, these data indicate that PIASc functions to promote faithful chromosome segregation, presumably by increasing the efficiency of decatenation, particularly at centromeres, but is dispensable for sister separation. It seems reasonable that human cells have evolved a mechanism to determine if decatenation cannot proceed efficiently, when Topo II activity is limited or in the absence of PIASc, and to respond by delaying anaphase onset by activation of a checkpoint. Such a defect could be detected by monitoring the presence of catenations, the proper localization of Topoisomerase II or by assessing PIASc activity.
In the experiments where we bypassed the prolonged metaphase delay seen in the absence of PIASc, many of the PIASc- depleted cells had been in metaphase for a considerable period of time before we added roscovitine or ZM447439. We can infer, then, that the catenations must have persisted despite the fact that Topoisomerase II is active in control metaphase cells. It is therefore plausible that sumoylation of Topoisomerase II helps to direct its decatenatory activity to centromeric catenations. This idea is consistent with the finding that PIASc sumoylates Topoisomerase II in Xenopus and yeast. However, we have not ruled out the possibility that PIASc promotes proper Topoisomerase II localization indirectly in human cells.
In summary, we have identified a human E3 sumo ligase required for efficient and timely anaphase separation of sister chromatids. Cells that lack PIASc arrest in metaphase with cohered sisters even in the absence of the cohesin guardian hSgo1, and without cohesin Rad21 being detectable at centromeres. Topoisomerase II does not concentrate at centromere regions in such cells and catenations remain between the sister chromatids. Therefore, we provide the first evidence that the mechanism of loss of cohesion in human cells involves removal of DNA catenations stimulated by PIASc. Moreover, our data indicate that catenations can act redundantly with cohesin complexes and that the failure to efficiently remove catenations triggers the spindle checkpoint.
MATERIALS AND METHODS
Cell culture and siRNA methods
Cells were grown at 37uC with 5% CO 2 in DMEM containing high glucose, L-glutamine, sodium pyruvate and pyridosine hydrochloride (Gibco) plus Penicillin-Streptomycin (100 U/mL-100 mg/mL, Gibco). Cell synchronies were performed by double thymidine (2 mM) arrest and release into complete medium. The siRNA and synchrony protocol used for PIASc depletion are depicted in Figure 1 . PIASc depleted using two different siRNA sequences gave similar results. Data presented here used PIASc-B: 59-GCUCUACGGAAAGUACUUA (dTdT)-39. siRNAs were transfected using Lipofectamine2000 (Invitrogen) using the manufacturer instructions. 6 hours after siRNA transfection, medium was changed to normal medium containing half the normal concentration of Penicillin-Streptomycin. Nocodazole was used at 0.5 mM in DMSO.
Cytology
For cytological analysis cells were fixed with Carnoy's and chromosome spreads prepared or with paraformaldehyde for immuno-staining, as previously described [13] . Antibodies: anti-CENP-E, 1:250 dilution (Immuquest); anti-myc, 1:1000 dilution (Gramsch Laboratories); anti-Topoisomerase IIa, 1:1000 dilution (CalBiochem). Rad21 was visualized in cells expressing myctagged Rad21 [49] . When quantifying cellular phenotypes a minimum of 1000 cells were counted per sample. Photomicrographs were acquired with a Zeiss Axioplan2 microscope, an alpha-Plan Fluar 1006/1.45 n.a. objective, and an AxioCam MRC5 camera with Axiovision software (Zeiss).
Biochemistry
Whole cell extracts were obtained and Western blots performed as previously described [13] 
Live cell imaging
HeLa cells were plated onto poly-d-lysine coated 35 mm tissue culture dishes fitted with glass cover-slips (MatTek Cultureware). siRNA transfection and thymidine synchrony was performed as described in Fig. 1 except that upon release from the second thymidine arrest, the standard medium containing the thymidine was exchanged for DMEM without phenol red, supplemented with 10% FBS, penicillin/streptomycin and 200 mM Trolox (Calbiochem). The dishes were transferred to a microscope humidified stage incubator containing 5% CO 2 at 37uC, 4 hours after release from the early S-phase block. Cells were filmed at 120 second intervals with three z-sections for 16-20 hours, using a Zeiss Axiovert 200M microscope fitted with a 406/1.3 n.a. PlanNeofluar objective, an Axiocam HRm camera and using Openlab software. following nuclear envelope breakdown was achieved in most PIASc-depleted cells (18/26) within a similar time frame to the control-treated cells. These data are consistent with the analysis of chromosome spreads in that they revealed normal metaphase plate formation in cells lacking PIASc. Once all of the chromosomes were correctly aligned at the plate, however, anaphase was not initiated on schedule in PIASc-depleted cells. In 4/20 cells, the metaphase period was very similar to the average metaphase length in control cells and other mitotic stages in these cells were also indistinguishable from the controls, indicating that these four cells may not have received PIASc-specific siRNA. Even including these cells in the analysis, the average time PIASc-depleted cells spent in metaphase was ,2.56 that observed in controls (110 minutes; s.d. = 78 minutes). The maximum metaphase length was 4 hours 10 minutes (,6 times longer than the average metaphase duration in control cells). After a prolonged period in metaphase, in 11/26 PIASc-depleted cells, individual chromosomes were seen to leave to the plate, usually reaching the spindle poles. Such chromosomes rarely moved back to the metaphase plate and these cells typically remained in this de-congressed metaphase state for at least another 3 hours. Because in the chromosome spreads ( Fig. 1 and Fig. S1 ) we observed very few separated sister chromatids and because we observed decongressed metaphases with greatly overcondensed chromosomes (Fig. 1H, Fig. S1N ,O), we assume that the chromosomes that left the plate had cohered centromeres (i.e. both sisters moved off the plate together). We cannot say whether these excursions are the cause of the prolonged pre-anaphase delay (perhaps by triggering a checkpoint subsequent to the metaphase-state being achieved), or whether the cells are unable to keep all of the chromosomes on the plate during the prolonged pre-anaphase delay. Remarkably, in some PIASc-depleted cells that first spent far longer in metaphase that control cells, anaphases ensued following the long metaphase-like delays. This was typically seen after prolonged metaphase arrest (the chromosomes are highly overcondensed indicating a prolonged mitotic block). In such cells, chromosomes off the plate regained strong CENP-E staining at their kinetochores (see Figure 3B -F). (P) Onset of anaphase in a PIASc-depleted cell (frequency is quantified in Fig. 1J ). In this cell, sisters separated asynchronously and arm separation was delayed. Such cells were most frequent after cells had been in metaphase for prolonged periods. It is possible that in such cells, PIASc-depletion was incomplete, or perhaps these cells had spontaneously leaked through the checkpoint arrest. Figure 1 (main text) were released from early S phase and mitotic cells possessing chromosomal damage were quantified. (G,H and J) The frequency of apoptotic cells was higher after PIASc-specific siRNA than control treated cells. (K) The number of cells that entered mitosis was reduced after PIASc-specific siRNA treatment compared with control cells (also see Fig. 1K ). To ask if chromosomal damage had arrested some PIASc-depleted cells in interphase (G2) we added caffeine (an inhibitor of ATM/ATR checkpoint kinases; 2 mM) as well as nocodazole to cells released from early S phase synchrony after PIASc-depletion. The nocodazole was added upon release and caffeine was added to samples in parallel after 14 hours. Caffeine treatment did not force cells treated with PIASc-specific siRNA into mitosis. Each horizontal bar represents a single cell analyzed in the video time-lapse studies. Asterisks (*) indicate cells in which the metaphase plate rotated in the cell so that our observation was from the polar aspect. Thereafter, in these cases we could not determine whether or not chromosomes left the plate. Number Sign (#) indicates cells in which we did not observe metaphase plate formation. In these cases, it is likely that the cells remained in prometaphase, but we cannot rule out the possibility that metaphase plates formed but that the plates remained positioned such that plate formation could not be observed. The grey region indicates cells that ultimately initiated anaphase. Table 1 summarizes the data obtained. Movie S2 20 hour time-lapse movie from a wide field of control HeLa cells expressing H2B-GFP and entering mitosis after the release from a double thymidine block. Statistical analysis is shown in Figure S3 and Table S1 . Selected frames from selected cells are shown in Fig. 2B . Movie S4 20 hour time-lapse movie from a wide field of PIAScdepleted HeLa cells expressing H2B-GFP and entering mitosis after the release from a double thymidine block. Statistical analysis is shown in Figure S3 and Table S1 . Selected frames from selected cells are shown in Fig. 2B 
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